The phosphoinositide 3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway plays a critical role in cell growth, tumor proliferation, and therapy resistance in breast cancer [45]. This evidence concerns the gene MTOR and breast carcinoma.